Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Mais filtros

Base de dados
Intervalo de ano de publicação
Mymensingh Med J ; 31(2): 333-336, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35383746


Recent COVID-19 pandemic has changed health resource disposal plan and urged relocation of work force to defend the world from devastation of this emerging disease. This cross-sectional observational study aims to categorize and rationalize COVID-19 testing of all patients attending flu corner of One Stop Service (OSS) in the department of Emergency and Casualty (E&C) in Mymensingh Medical College Hospital (MMCH) during 15th April 2021 to 14th May 2021 on 2627 patients as per inclusion and exclusion criteria. Out of 2627 patients 920(35%) were symptomatic cases and 1707(65%) attended for testing without symptom. Out of 920 symptomatic cases 175(19%) were confirmed COVID-19 cases. Among the confirmed cases 38(21.71%) was admitted whereas, from suspected cases 100(13.42%) got admitted, remaining patients from both categories were advised for home isolation. Coverage and justification of COVID-19 testing should be done precisely to ensure proper disease control and COVID care during this pandemic.

COVID-19 , COVID-19/diagnóstico , COVID-19/epidemiologia , Teste para COVID-19 , Estudos Transversais , Hospitais , Humanos , Pandemias
Mymensingh Med J ; 30(4): 903-906, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34605454


Retrocalcaneal bursitis is one of the important causes of posterior heel pain which is due to repetitive friction of the retrocalcaneal bursa between the postero-superior calcaneal tuberosity (haglund deformity) and Achilles tendon. Most of the patients are treated by conservative methods. But when the condition becomes chronic and not responding to the conservative treatment, surgical treatment is an option of these cases. This prospective interventional study was conducted in the Department of Orthopaedic Surgery, BSMMU (Bangabandhu Sheikh Mujib Medical University), Dhaka, Bangladesh from September 2017 to August 2019. Within this period, total 40 cases of chronic retrocalcaneal bursitis were operated at BSMMU. The clinical and functional outcome was evaluated according to AOFAS (American Orthopedic Foot Ankle Society) scale. The results of this study showed significantly improvement of pain, functional status and deformity at the time of final follow-up period of 1 year, total mean score improved from 46/100 to 89/100. The outcome of the subjects was satisfactory 90% and unsatisfactory 10%. Surgical intervention is an effective option of treatment with satisfactory outcome, in the treatment of chronic retrocalcaneal bursitis.

Tendão do Calcâneo , Bursite , Calcâneo , Bangladesh , Bursite/cirurgia , Calcâneo/diagnóstico por imagem , Calcâneo/cirurgia , Humanos , Estudos Prospectivos , Resultado do Tratamento
Mymensingh Med J ; 22(1): 64-8, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23416811


The Platelet (PLT) Transfusion Therapy plays an important role in the support of surgical, haematological, oncological and transplant patients. The present study was assigned to find out the post transfusion increment of platelet count among the thrombocytopenic patients in Bangladeshi population. This descriptive study was conducted at the Departments of Haematology and Transfusion Medicine, BSMMU, Dhaka. Total 42 thrmbocytopenic patients were randomly assigned to receive a transfusion when their platelet counts below 10000 per cubic millimeter or with active bleeding. Pre transfusion and post transfusion platelet count were measured in all patients. Out of 42 patients, 26(61.90%) were male and 16(38.10%) were female. Leukemia was the most common cause of thrombocytopenia (47.62%). Most of the patients (71.34%) required transfusion of multiple units of platelet and 12(28.57%) patients required double units. Before transfusion of platelet concentrate <30×108/L, 30-80×108/L and >80×108/L platelet count were found in 30(71.43%), 08(19.05%) and 04(09.52%) patients respectively. After transfusion of platelet concentrate <50×108/L, 50-100×108/L and >100×108/L platelet count were found in 30(71.43%), 08(19.05%) and 04(09.52%) patients respectively. In all patients post transfusion platelet count increases but 2 or multiple units of transfusion were needed.

Hemorragia/terapia , Transfusão de Plaquetas , Plasma Rico em Plaquetas , Trombocitopenia/terapia , Adulto , Antineoplásicos/efeitos adversos , Bangladesh , Dengue/complicações , Feminino , Hemorragia/sangue , Hemorragia/etiologia , Humanos , Leucemia/complicações , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Púrpura Trombocitopênica/sangue , Púrpura Trombocitopênica/etiologia , Púrpura Trombocitopênica/terapia , Trombocitopenia/sangue , Trombocitopenia/etiologia , Resultado do Tratamento , Adulto Jovem
Proc Natl Acad Sci U S A ; 90(21): 10255-9, 1993 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-8234286


Fusion of intracellular membrane-bound compartments is a common step in the transport of macromolecules along the endocytic and secretory pathways. A large number of factors active in the fusion process or its regulation have been identified; however, the actual sequence of events leading to membrane fusion is still unknown. In this study, we have assessed a possible role for PLA2 in endosome fusion by using an in vitro reconstitution assay and by examining endocytosis in intact cells. Several PLA2 inhibitors blocked endosome fusion in a broken-cell preparation. Inhibition was reversed by addition of arachidonic acid. At the electron microscope level, endosome clusters were observed even in the presence of inhibitors; however, actual fusion between endosomes was largely reduced. Fusion frequency increased upon the addition of arachidonic acid. A membrane-permeable PLA2 inhibitor blocked mixing of ligands internalized sequentially but did not affect internalization. The results indicate that vesicle fusion along the endocytic pathway requires a PLA2 activity. The effect of this activity would be, at least in part, mediated by arachidonic acid release.

Ácido Araquidônico/farmacologia , Endocitose , Inibidores Enzimáticos/farmacologia , Organelas/fisiologia , Fosfolipases A/metabolismo , Animais , Anticorpos Monoclonais , Linhagem Celular , Membrana Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Membrana Celular/ultraestrutura , Endocitose/efeitos dos fármacos , Cinética , Macrófagos , Fusão de Membrana/efeitos dos fármacos , Microscopia Eletrônica , Organelas/efeitos dos fármacos , Organelas/ultraestrutura , Fosfolipases A/antagonistas & inibidores , Fosfolipases A2